Approximately 100 million American adults suffer from chronic pain with an estimated societal cost of $600 billion annually. 

Chronic pain continues to be an enormous unmet medical need with a far-reaching impact on society.

ProNeurogen’s PNA5 Drug Candidate

Novel approach – new drug class

Efficacious for chronic and inflammatory pain

Extremely safe e.g., non-addictive with preclinical studies showing no side-effects